INSP - Inspire Medical Systems, Inc.

Inspire Medical Systems, Inc. Announces Events at SLEEP 2023, the 37th Annual Meeting of the Associated Professional Sleep Societies

MINNEAPOLIS, June 05, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that it will have a significant presence at SLEEP 2023, taking place June 3 - 7, 2023 in Indianapolis, IN. SLEEP 2023 is the 37th annual meeting of the Associated Professional Sleep Societies (APSS), a joint venture of

• 
  Blood donation, Boys & Girls Clubs, and a porta-potty on the move in The Bubbler on June 8, 2023

  WITI
• 
  MLW Fusion Results – June 8, 2023: John Hennigan Defends Against Willie Mack

  Wrestle Zone

Inspire Medical Systems, Inc. to Participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series

MINNEAPOLIS, May 16, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will participate in the Wells Fargo 2023 Medtech Innovation Spotlight Series on Monday, May 22, 2023. Inspire is scheduled to present at 2:00 p.m. Eastern Time. The presentation will be accessib

UPDATE - Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023. Inspire is now scheduled to present at 1:00 p.m. Eastern Time. The presentation will be accessible via

Inspire Medical Systems, Inc. to Present at the RBC Capital Markets 2023 Global Healthcare Conference

MINNEAPOLIS, May 03, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the RBC Capital Markets 2023 Global Healthcare Conference on Tuesday, May 16, 2023. Inspire is scheduled to present at 1:35 p.m. Eastern Time. The presentation will be accessible

Inspire Medical Systems, Inc. Announces First Quarter 2023 Financial Results and Updates 2023 Outlook

Inspire Reports Year-over-Year Revenue Growth of 84% in the First QuarterMINNEAPOLIS, May 02, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today reported financial results for the quarter ended March 31, 2023. Recent Business Highlights Generated revenue of $127.9 million in the first quarter o

Inspire Medical Systems, Inc. to Present at the BofA Securities Health Care Conference 2023

MINNEAPOLIS, April 26, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the BofA Securities Health Care Conference 2023 on Wednesday, May 10, 2023. Inspire is scheduled to present at 11:40 a.m. Eastern Time. The presentation will be accessible via

Inspire Medical Systems, Inc. to Report First Quarter 2023 Financial Results on May 2, 2023

MINNEAPOLIS, April 04, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2023 after the close of trading on Tuesday, May 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspir

Inspire Medical Systems, Inc. Announces FDA Approval for Pediatric Patients with Down Syndrome

MINNEAPOLIS, March 21, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received approval from the Food and Drug Administration (FDA) to offer Inspire therapy to pediatric patients with Down syndrome. “Since our first FDA approval in 2014, the research team at Mass Eye a

Inspire Medical Systems, Inc. Announces Countrywide Reimbursement in Belgium

MINNEAPOLIS, March 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today that it has received countrywide reimbursement approval in Belgium, effective immediately, at rates consistent with other countries around the world. “The healthcare team at Antwerp University Hospital (UZA) in

Inspire Medical Systems, Inc. to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

MINNEAPOLIS, March 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the virtual KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Tuesday, March 21, 2023. Inspire is scheduled to present at 9:00 a.m. Eastern Time. The presentati

Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Guidance

Inspire Reports First Profitable Quarter and Year-over-Year Revenue Growth of 76% in the Fourth QuarterMINNEAPOLIS, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter and full year ended December 31, 2022, and provided full year 2023 guidance. Recen

Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2022 Financial Results on February 7, 2023

MINNEAPOLIS, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2022 after the close of trading on Tuesday, February 7. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through t

Inspire Medical Systems, Inc. Announces Preliminary Results for the Fourth Quarter and Full Year 2022

MINNEAPOLIS, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced certain preliminary, unaudited results for the quarter and full year ended December 31, 2022. Preliminary, Unaudited Revenue and Recent Business Highlights Revenue for the fourth quarter of 2022 is anticipated to be in

Inspire Medical Systems, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference

MINNEAPOLIS, Dec. 21, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the 41st Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2023 at the Westin St. Francis Hotel in San Francisco, CA. Inspire is scheduled to present at 8:15 a.m. P

Inspire Medical Systems, Inc. Publishes Inaugural ESG Summary Report

Inspire Adopts SASB Reporting StandardsMINNEAPOLIS, Dec. 20, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, published its inaugural Environmental, Social, and Governance (ESG) Summary Report. “We are pleased to present our inaugural ESG Summary Report, in which our aim is to address the diverse interes

Inspire Medical Systems, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference

MINNEAPOLIS, Nov. 16, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Piper Sandler 34th Annual Healthcare Conference on Wednesday, November 30, 2022 at the Lotte New York Palace Hotel in New York, NY. Inspire is scheduled to present at 3:30 p

Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference

MINNEAPOLIS, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Stifel 2022 Healthcare Conference on Wednesday, November 16, 2022 at the Lotte New York Palace Hotel in New York, NY. Inspire is scheduled to present at 2:25 p.m. Eastern Ti

Inspire Medical Systems, Inc. Announces Third Quarter 2022 Financial Results and Updates 2022 Outlook

Inspire Reports Year-over-Year Revenue Growth of 77% in the Third QuarterMINNEAPOLIS, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended September 30, 2022. Recent Business Highlights Generated revenue of $109.2 million in the third quarter of

Inspire Medical Systems, Inc. to Report Third Quarter 2022 Financial Results on November 1, 2022

MINNEAPOLIS, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the third quarter 2022 after the close of trading on Tuesday, November 1. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments. To access the call, please use the following link: Inspire's Q3 2022 earnings call. After registering, an email will be

Inspire Medical Systems, Inc. Announces Updates from International Surgical Sleep Society and American Academy of Otolaryngology – Head and Neck Surgery Meetings

MINNEAPOLIS, Sept. 14, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today key updates from the International Surgical Sleep Society (ISSS) and American Academy of Otolaryngology (AAO-HNSF) meetings which took place in Philadelphia September 9-14th. “We were excited to return to in-person co

Inspire Medical Systems, Inc. to Present at the Wells Fargo 2022 Healthcare Conference

MINNEAPOLIS, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today that its management team will present at the Wells Fargo 2022 Healthcare Conference on Thursday, September 8, 2022 at the Encore Boston Harbor in Boston, MA. Inspire is scheduled to present at 3:10 p.m. Eastern Time. T

Inspire Medical Systems, Inc. Announces Appointment of Ezgi Yagci as Vice President of Investor Relations

MINNEAPOLIS, Aug. 15, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced the appointment of Ezgi Yagci as Vice President of Investor Relations, effective August 15, 2022. "The team is very excited to welcome Ezgi and her vast experience in the medical technology sector to Inspire,” said Tim

Inspire Medical Systems, Inc. Announces Pricing of Offering of Common Stock

MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the pricing of an underwritten public offering of 1,000,000 shares of its common stock, at a public offering price of $215.00 per share, before underwriting discounts and commissions. In addition, Inspire has granted

Inspire Medical Systems, Inc. Announces Proposed Offering of Common Stock

MINNEAPOLIS, Aug. 11, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the commencement of a proposed public offering of 1,000,000 shares of its common stock. Inspire also expects to grant the underwriter a 30-day option to purchase up to an additional 150,000 shares of its common stock

Inspire Medical Systems, Inc. Announces Second Quarter 2022 Financial Results and Updates 2022 Outlook

Inspire Reports Year-over-Year Revenue Growth of 73% in the Second QuarterMINNEAPOLIS, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financial results for the quarter ended June 30, 2022. Recent Business Highlights Generated revenue of $91.4 million in the second quarter of 202